WebMD is laying off 14% of its workforce in hopes of saving $45 million to offset revenue losses from an ad slump that plagued the portal throughout 2012.
Pushing back against complaints that the drug approvals process moves too slowly in the US, FDA issued a report saying it kept pace with its 2011 showing
With the impending US approval of their oral blood thinner, this could be a big year for Bristol-Myers Squibb. But the other two warfarin replacements will continue to play important roles. Noah Pines sets the scene
2013 All-Star Media Brand of the Year: Everyday Health